Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

Overview of attention for article published in Lung Cancer: Targets and Therapy, November 2019

Altmetric Badge

Mentioned by

reddit: 1 Redditor

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 6 Mendeley

Summary Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

User montaukwhaler, in the non small cell lung cancer subreddit, 15 Nov 2019